---
title: "Pharmacokinetics"
subtitle: "Dose-Exposure"
date: last-modified
---

> "What the body does to the drug"

## Executive summary

**Pharmacokinetics (PK)** asks a single question:  

> *“Given an input (dose & regimen), what exposure (concentration-time profile) will the body create?”*

This page is your quick-reference for that mapping. It is organised as follows:

| Section | What you get | Key take-aways |
|---------|--------------|----------------|
| **Therapeutic window** | Where efficacy ⇢ safety overlap | Target *C~min~* and *C~max~* |
| **Single-dose kinetics** | IV bolus + oral equations | How *V~d~* and *k~e~* shape curves |
| **Repeated/continuous input** | Multiple-dose & infusion profiles | Why accumulation ratio (*R~ac~*) matters |
| **Equations at a glance** | One-liner table of canonical PK formulae | Copy-paste cheatsheet |
| **Deep dives** | Absorption · Distribution · Elimination | Mechanistic levers behind each parameter |

Use the overview to **choose the right regimen**, then jump to the deep-dive pages when you need mechanism-level detail.

## Key symbols and canonical equations

| Symbol | Description |
| :----: | :---------- |
| $\D$ | Dose |
| $\ii$ | Dosing interval (interdose interval) |
| $\CL$ | Clearance |
| $\Vd$ | Volume of distribution |
| $\ke$ | Elimination rate constant |
| $\ka$ | Absorption rate constant |
| $\F$ | Bioavailability |
| $\Rin$ | Infusion rate |
| $T_\text{inf}$ | Duration of infusion |
| $\Cpl$ | Plasma concentration |
| $\mathrm{R_ac}$ | Accumulation ratio |

: Pharmacokinetic symbols {#tbl-pk-symbols tbl-colwidths="[20, 80]"}

### Clearance (CL)

$$
\CL = \frac{\D \times \F}{\AUCinf} \;=\; \ke \times \Vd
$$ {#eq-cl-1cmt}

## Therapeutic window

```{r}
#| label: fig-therapeutic-window
#| fig-cap: "Concentration–time profile and the therapeutic window."
#| fig.align: "center"

tibble::tibble(
  time = c(0, 0.5, 1, 2, 4, 6, 8, 12), # h
  conc = c(0, 14, 12, 9, 6, 4, 3, 0) # mg/L (example)
) |>
ggplot2::ggplot(ggplot2::aes(time, conc)) +
  ggplot2::annotate( # shaded window
    "rect",
    xmin = -Inf,
    xmax = Inf,
    ymin = 3,
    ymax = 10,
    alpha = 0.08,
    fill = "forestgreen"
  ) +
  ggplot2::geom_line(linewidth = 1) +
  ggplot2::geom_hline(yintercept = 3, linetype = "dashed") + # MEC
  ggplot2::geom_hline(yintercept = 10, linetype = "dashed") + # MTC
  ggplot2::labs(
    x = "Time (h)",
    y = "Concentration (mg/L)"
  ) +
  ggplot2::annotate( # labels
    "text",
    x = 11.5,
    y = 10.4,
    hjust = 1,
    label = "Safety threshold",
    size = 3
  ) +
  ggplot2::annotate(
    "text",
    x = 11.5,
    y = 3.4,
    hjust = 1,
    label = "Efficacy threshold",
    size = 3
  ) +
  ggplot2::theme_minimal()
```

## Single-dose kinetics

### Intravenous bolus

#### Single i.v. dose

Initial concentration @eq-c0-iv.

$$
\C_0 = \frac{\D}{\Vd}
$$ {#eq-c0-iv}

Plasma concentration @eq-c-single-iv-dose-1cmt.

$$
\C(t) = \C_0 \times e^{-\ke \times t}
$$ {#eq-c-single-iv-dose-1cmt}

#### Multiple i.v. doses

$$
\C_n(t) =
  \frac{\D}{\Vd} \times
  \frac{
    \left(1 - e^{-n \times \ke \times \ii}\right)
  }{
    \left(1 - e^{-\ke \times \ii}\right)
  } \times
  e^{-\ke \times t}
$$

at peak: $t = 0$; at steady state $\mathrm{n} \rightarrow \infty$; at trough: $t = \ii$

$$
\C_\text{max, ss} =
  \frac{\D}{\V} \times
  \frac{1}{\left(1 - e^{-\ke \ii} \right)}
$$ {#eq-cmaxss-multiple-iv-dose-1cmt}

$$
\C_\text{min, ss} = \C_\text{max, ss} \times e^{-\ke \times \ii}
$$ {#eq-cminss-multiple-iv-dose-1cmt}

Plasma concentration @eq-c-multiple-iv-dose-1cmt.

$$
\C(t) = \Cmax \times e^{-\ke \times t}
$$ {#eq-c-multiple-iv-dose-1cmt}

Peak @eq-cmax-multiple-iv-dose-1cmt.

$$
\Cmax =
  \frac{
    \C_0
  }{
    1 - e^{-\ke \times \ii}
  }
$$ {#eq-cmax-multiple-iv-dose-1cmt}

Trough @eq-cmin-multiple-iv-dose-1cmt.

$$
\Cmin = \Cmax \times e^{-\ke \times \ii}
$$ {#eq-cmin-multiple-iv-dose-1cmt}

Average concentration (steady state) @eq-cavgss-multiple-iv-dose-1cmt.

$$
\bar{\C}_\text{pl, ss} = \frac{\D}{\CL \times \ii}
$$ {#eq-cavgss-multiple-iv-dose-1cmt}

### Oral administration

#### Single p.o. dose

Plasma concentration @eq-c-single-po-dose-1cmt.

$$
\C =
  \frac{
    \F \times \D \times \ka
  }{
    \Vd \left(\ka - \ke \right)
  }
  \left(
    e^{-\ke \times t} - e^{-\ka \times t}
  \right)
$$ {#eq-c-single-po-dose-1cmt}

Time of maximum concentration @eq-tmax-single-po-dose-1cmt.

$$
t_\text{max} =
  \frac{
    \ln \left(\ka / \ke \right)
  }{
    \ka - \ke
  }
$$ {#eq-tmax-single-po-dose-1cmt}

#### Multiple p.o. doses

Plasma concentration @eq-c-multiple-po-dose-1cmt.

$$
\C =
\frac{
  \F \times \D \times \ka
}{
  \Vd (\ka - \ke)
}
\left(
  \frac{
    e^{-\ke \times t}
  }{
    1 - e^{-\ke \times \ii}
  } -
  \frac{
    e^{-\ka \times t}
  }{
    1 - e^{-\ka \times \ii}
  }
\right)
$$ {#eq-c-multiple-po-dose-1cmt}

Time of maximum concentration @eq-tmax-multiple-po-dose-1cmt.

$$
t_\text{max} =
  \frac{
    \ln
      \left(
        \frac{
          \ka \times \left(1 - e^{-\ke \times \ii} \right)
        }{
          \ke \times \left(1 - e^{-\ka \times \ii} \right)
        }
      \right)
  }{
    \left(\ka - \ke}\right)
  }
$$ {#eq-tmax-multiple-po-dose-1cmt}

Average concentration (steady state) @eq-cavgss-multiple-po-dose-1cmt.

$$
\bar{\C} =
  \frac{
    \F \times \D
  }{
    \CL \times \ii
  }
$$ {#eq-cavgss-multiple-po-dose-1cmt}

### Intravenous infusion

$$
\Rin = \frac{\D}{T}
$$

Plasma concentration (steady state) @eq-css-ctsinf-1cmt

$$
\Cplss = \frac{\Rin}{\CL}
$$ {#eq-css-ctsinf-1cmt}

Plasma concentration (during infusion) @eq-c-ctsinf-1cmt

$$
\C(t) = \frac{\Rin}{\CL}
\left(
  1 - e^{-\ke \times t}
\right)
$$ {#eq-c-ctsinf-1cmt}

Calculated clearance (Chiou equation) @eq-cl-ctsinf-chiou

$$
\CL =
  \frac{2 \Rin}{\left(\C_1 + \C_2 \right)} +
  \frac{
    2 \Vd \left(\C_1 - \C_2 \right)
  }{
    \left(\C_1 + \C_2 \right) \left(t_2 - t_1 \right)
  }
$$ {#eq-cl-ctsinf-chiou}

### Single infusion

Since $\ii = t$ for $\Cmax$

Peak @eq-cmax-single-infusion-1cmt

$$
\Cmax = \frac{\Rin}{\CL} \left(1 -e ^{-\ke T} \right)
$$ {#eq-cmax-single-infusion-1cmt}

Trough @eq-cmin-single-infusion-1cmt

$$
\Cmin = \Cmax \times e^{-\ke (\ii - T)}
$$ {#eq-cmin-single-infusion-1cmt}

#### Multiple infusions

Peak @eq-cmax-multiple-infusion-1cmt.

$$
\Cmax =
  \frac{\Rin}{\CL} \times
  \frac{
    \left(1 - e^{-\ke \times T} \right)
  }{
    \left(1 - e^{-\ke \times \ii} \right)
  }
$$ {#eq-cmax-multiple-infusion-1cmt}

Trough @eq-cmin-multiple-infusion-1cmt.

$$
\Cmin =
  \Cmax \times e^{-\ke (\ii - T)}
$$ {#eq-cmin-multiple-infusion-1cmt}

#### Calculated parameters

Calculated elimination rate constant (1-compartment case) @eq-ke-1cmt.  
With C^\*^~max~ = measured peak and C^\*^min = measured trough, measured over the time interval $\Delta t$
$$
\ke =
  \frac{
    \ln \left(\frac{\Cmax^*}{\Cmin^*} \right)
  }{
    \Delta t
  }
$$ {#eq-ke-1cmt}

Calculated peak @eq-cmax-calc-multiple-infusion-1cmt.  
With C^\*^~max~ = measured peak, measured at time t^\*^ after the end of the infusion

$$
\Cmax = \frac{\Cmax^*}{e^{-\ke t^*}}
$$ {#eq-cmax-calc-multiple-infusion-1cmt}

Calculated trough @eq-cmin-calc-multiple-infusion-1cmt.  
With C^\*^min = measured trough, measured at time t^\*^ before the start of the next infusion

$$
\Cmin = \Cmin^* \times e^{-\ke \times t^*}
$$ {#eq-cmin-calc-multiple-infusion-1cmt}

Calculated volume of distribution @eq-vd-calc-multiple-infusion-1cmt.

$$
\Vd =
  \frac{\Rin}{\ke}
  \times
  \frac{
    \left(1 - e^{-\ke \times T}\right)
  }{
    \left[
      \Cmax - \left(\Cmin \times e^{-\ke \times T} \right)
    \right]
  }
$$ {#eq-vd-calc-multiple-infusion-1cmt}

Calculated recommended dosing interval for infusion start @eq-ii-calc-multiple-infusion-1cmt.

$$
\ii =
  \frac{
    \ln
    \left(
      \frac{
        \C_\text{max, desired}
      }{
        \C_\text{min, desired}
      }
    \right)
  }{
    \ke
  } + T
$$ {#eq-ii-calc-multiple-infusion-1cmt}

Calculated recommended dose @eq-dose-calc-multiple-infusion-1cmt.

$$
\D =
  \C_\text{max, desired} \times \ke \times \V \times T
  \frac{
    \left(1 - e^{-\ke \ii}\right)
  }{
    \left(1 - e^{-\ke T} \right)
  }
$$ {#eq-dose-calc-multiple-infusion-1cmt}

## Multiple-dose kinetics

## Two-compartment PK model

$$
\C = a \times e^{-\alpha t} + b \times e^{-\rho t}
$$ {#eq-c-2cmt}

$$
\AUCinf = a / \alpha + b / \beta
$$ {#eq-auc-2cmt}

$$
\V_\text{d, area} > \V_\text{ss} > \V_\text{c}
$$ {#eq-v-2cmt}

Vd_area = V beta?

## Dosage regimens

$$
\C_\text{inf} = \C_\text{ss} \times \left(1 - e^{-\ke t}\right)
$$
(1-compartment)

$$
\C_\text{ss, avg} = \F \times \D /(\CL \times \ii)
$$
(variation of eq. 24)

$$
\mathrm{R_ac} = 1 / \left(1 - e^{-\ke \ii}\right)
$$
(1-compartment)

$$
\C_\text{ss, max} = \F \times \D \times \mathrm{R_ac} / \V
$$
(1-compartment)

$$
\C_\text{ss, min} =
  \C_\text{ss, max} \times e^{-k \times \ii}
$$
(1-compartment, combination of eq. 22 and 28)

$$
\ii_\text{max} =
  \ln
    \left(
      \C_\text{ss, max} / \C_\text{ss, min}
    \right) / \ke
$$
(1-compartment, variation of eq. 23)

$$
\text{Corresponding dose} \times \F =
  \V \times\left(\C_\text{max, ss} - \C_\text{min, ss}\right)
$$
(1-compartment)

### Exposure (AUC)

$$
\AUC_\text{iv} =
  \C_0 / \ke
$$
(1-compartment)

$$
\AUC_\text{iv} =
  \C_1 / \lambda_1 + \C_2 / \lambda_2
$$
(2-compartment)

$$
\AUC =
  \Sigma(\text{trapezoids}) +
  \C_\text{last} / \ke
$$
(Always applicable)

## Things that can affect PK

### Sex

Common covariate.
Males and females have different genetic physiological composition that are similar within the groups.
Thus, "sex" is really a surrogate covariate for genetic and physiological variability.

Females have ~15% lower kidney function than males.
Metabolism by CYP3A is not expected to differ between sexes.

This does **not** include **pregnant women**, which can have different physiological processes.

### Age

Age is a common covariate in PK because body composition and physiology change over time.

Children differ substantially from adults in terms of physiology.
During late adolescence, physiological changes stabilize, but gradual alterations continue throughout adulthood.

In most adult patients, dose adjustments based on age are not necessary, as their age is typically close to that of the "typical" patient used for dose selection.
However, adjustment may be warranted when the patient’s age deviates by more than 20 years from the typical reference age.

As adults age, organ function declines, especially renal function.
This is reflected in commonly used kidney function equations, many of which include age as a predictor.

* **Kidney function decreases by approximately 1% per year in adults.**
* Metabolic clearance also tends to decline with age.

Therefore, including age as a covariate on drug clearance is always a sensible choice.

### Weight

#### Ideal Body Weight

##### Male

IBW = 50 kg + 2.3 kg for each inch over 5ft in height

##### Female

IBW = 45.5 kg + 2.3 kg for each inch over 5ft in height

##### Obese

ABW = IBW + 0.4 * (TBW-IBW)

### Disease

### Genetics

#### Race

### DDI
